Clinical Trial Update: Low-Cost Molecular Cervical Cancer Screening Study

View source ↗

Summary

A completed clinical trial evaluating a low-cost molecular screening method for cervical cancer that uses DNA probes and HPV E6 protein detection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Human Papillomavirus Infection

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: DNA Probes, E6 Protein | Status: COMPLETED